Skip to main content
. 2020 Sep 3;75(12):1112–1115. doi: 10.1136/thoraxjnl-2020-214656

Figure 2.

Figure 2

Supralethal influenza challenge in mice expressing T13B antibody via the rSIV.F/HN vector. Mice (n=5–6 per group) were dosed intranasally with rSIV.F/HN.hCEF.T13B at a dose of 1E7 TU (blue), 1e8 TU (red), 2.7e8 TU (magenta) or with 1e8 TU (black) of rSIV.F/HN.hCEF.GLux (Gaussia Luciferase) as mock control. (A–D) BALB/c mice were challenged with 10 or 100 median lethal dose (LD50) of H1N1 A/PR/8/1934 (Cambridge). (E, F) DBA/2 mice were challenged with 10 LD50 of reassortant pandemic H1N1 A/CA/7/2009-X179A. Body weight was measured daily for 14 days and mice were euthanised if weight loss declined ≥20% as depicted in the Kaplan-Meier survival curve (right column). SIV, simian immunodeficiency virus; TU, transducing units.